updates from the lymphoma & cll session: clinical trials, novel agents, and more
Published 2 years ago • 253 plays • Length 7:50Download video MP4
Download video MP3
Similar videos
-
1:19
updates in cml: recent trials and novel agents
-
1:24
novel agents for the treatment of hodgkin lymphoma: brentuximab vedotin and nivolumab
-
1:20
improving patient outcomes in ctcl: clinical collaboration and novel agents
-
2:23
results from the phase ii elm-2 trial: odronextamab for r/r follicular lymphoma
-
1:28
the remaining hurdles for using ctdna in lymphoma
-
11:47
petscan results. warning...not what we hoped for.
-
9:25
mgus diagnosis: a step-by-step approach
-
10:43
immunotherapy and lymphoma treatment
-
2:42
the current role of chemotherapy in the treatment of hodgkin lymphoma & the impact of novel agents
-
2:19
latest updates in lymphoma trials
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
9:52
myeloma highlights from soho 2023: updates with the use of novel targeted immunotherapies
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
1:18
hodgkin lymphoma highlights at ash 2022 and future outlooks
-
1:44
updates from the phase ii animate trial of nivolumab in r/r chl
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:14
promising novel agents in aml: menin inhibitors
-
2:15
updates from the phase ii aern trial: nivolumab and radiotherapy for the treatment of r/r hl
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:40
updates on the use of molecular monitoring to detect mrd in aml